Induction Chemotherapy Followed by Concurrent Full-dose Gemcitabine and Intensity-modulated Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
Intensity-modulated Radiation Therapy for Anal Cancer
Phase I Study of Docetaxel Plus Nedaplatin in Patients With Metastatic or Recurrent Esophageal Squamous Cell Carcinoma After Cisplatin Plus 5-Fluorouracil Treatment
Longer Course of Induction Chemotherapy Followed by Chemoradiation Favors Better Survival Outcomes for Patients With Locally Advanced Pancreatic Cancer
Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck
Extraskeletal Osteosarcoma
Evaluation of Clinical and Pathologic Risk Factors May Reduce the Rate of Multimodality Treatment of Early Cervical Cancer
Mucinous Adenocarcinoma of the Endometrium Compared With Endometrioid Endometrial Cancer
Long-term Outcome After Fractionated Radiotherapy for Pituitary Adenoma
Clinical and Demographic Factors Associated With Receipt of Non Guideline-concordant Initial Therapy for Nonmetastatic Prostate Cancer
Management of Postprostatectomy Biochemical Relapse With Salvage Radiotherapy
Treatment of Small Cell Carcinoma of the Bladder With Chemotherapy and Radiation after Transurethral Resection of a Bladder Tumor
Off-Target Effects of BCR-ABL and JAK2 Inhibitors
Academic and Resident Radiation Oncologists’ Attitudes and Intentions Regarding Radiation Therapy near the End of Life
Regional Nodal Irradiation
Treating Locally Advanced Cervical Cancer With Concurrent Chemoradiation Without Brachytherapy in Low-resource Countries
CTLA-4 and PD-1 Pathways
Pitfalls of Personalizing Cancer Treatment